Hudock, Inc. - NOVOCURE LTD ownership

NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 264 filers reported holding NOVOCURE LTD in Q2 2020. The put-call ratio across all filers is 1.62 and the average weighting 0.1%.

Quarter-by-quarter ownership
Hudock, Inc. ownership history of NOVOCURE LTD
ValueSharesWeighting
Q3 2022$37,000
+8.8%
5000.0%0.01%
+9.1%
Q2 2022$34,000
-17.1%
5000.0%0.01%0.0%
Q1 2022$41,000
+10.8%
5000.0%0.01%
+10.0%
Q4 2021$37,000
-36.2%
5000.0%0.01%
-41.2%
Q3 2021$58,000
-47.3%
5000.0%0.02%
-48.5%
Q2 2021$110,000
+66.7%
5000.0%0.03%
+57.1%
Q1 2021$66,000
-23.3%
5000.0%0.02%
-25.0%
Q4 2020$86,000
+56.4%
5000.0%0.03%
+40.0%
Q3 2020$55,000
+139.1%
500
+25.0%
0.02%
+150.0%
Q2 2020$23,000
-11.5%
4000.0%0.01%
-20.0%
Q1 2020$26,0004000.01%
Other shareholders
NOVOCURE LTD shareholders Q2 2020
NameSharesValueWeighting ↓
StepStone Group LP 115,479$7,302,00011.05%
HARTLINE INVESTMENT CORP/ 335,585$21,219,0005.07%
Darsana Capital Partners LP 1,500,000$94,845,0003.08%
Rhenman & Partners Asset Management AB 365,899$23,136,0002.55%
COURAGE CAPITAL MANAGEMENT LLC 20,000$1,265,0002.15%
Taylor Frigon Capital Management LLC 46,599$2,946,0002.04%
Granite Investment Partners, LLC 411,659$26,029,0001.40%
Nicholas Investment Partners, LP 146,106$9,238,0000.85%
Baillie Gifford 8,829,449$558,287,0000.59%
Cortina Asset Management, LLC 141,352$8,938,0000.55%
View complete list of NOVOCURE LTD shareholders